Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ckj/sfx104 http://scihub22266oqcxt.onion/10.1093/ckj/sfx104 C5887274!5887274 !29644062     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\29644062 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Clin+Kidney+J 2018 ; 11 (2 ): 219-221 Nephropedia Template TP {{tp|p=29644062 |t=2018. Granulomatous interstitial nephritis secondary to adalimumab therapy |pdf=|usr=}}{{29644062 }} gab.com Text Granulomatous interstitial nephritis secondary to adalimumab therapy JO: Clin Kidney J http://www.kidney.de/pget.php?&tw=1&pmid=29644062 #FOAvip Tumour necrosis factor ? (TNF-?) inhibitors are frequently used for the treatment of immune-mediated diseases. Conversely, cytokine therapy has the potential to paradoxically induce autoimmunity. A number of case reports have emerged concerning sarcoid-like granulomatosis secondary to TNF-? therapy, an adverse effect that typically affects the pulmonary and cutaneous systems. Granulomatous interstitial nephritis (GIN) is a relatively unknown, relatively under-reported consequence of adalimumab therapy that can have important clinical implications. To our knowledge, this is the first case report of GIN secondary to anti-TNF-? therapy necessitating a prolonged period of dialysis and the first report demonstrating the successful use of secukinumab as an alternative immunomodulatory agent. Twit Text FOAVip Granulomatous interstitial nephritis secondary to adalimumab therapy ????Clin Kidney J http://www.kidney.de/pget.php?&tw=1&pmid=29644062 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29644062 #FOAvip English Wikipedia <ref>{{Cite pmid|29644062 }}</ref> Granulomatous interstitial nephritis secondary to adalimumab therapy #MMPMID29644062 Sandys V ; Moloney B ; Lane L ; Qazi J ; Doyle B ; Barry M ; Leavey S ; Conlon P Clin Kidney J 2018[Apr]; 11 (2 ): 219-221 PMID29644062 show ga Tumour necrosis factor ? (TNF-?) inhibitors are frequently used for the treatment of immune-mediated diseases. Conversely, cytokine therapy has the potential to paradoxically induce autoimmunity. A number of case reports have emerged concerning sarcoid-like granulomatosis secondary to TNF-? therapy, an adverse effect that typically affects the pulmonary and cutaneous systems. Granulomatous interstitial nephritis (GIN) is a relatively unknown, relatively under-reported consequence of adalimumab therapy that can have important clinical implications. To our knowledge, this is the first case report of GIN secondary to anti-TNF-? therapy necessitating a prolonged period of dialysis and the first report demonstrating the successful use of secukinumab as an alternative immunomodulatory agent. äGranulomatous interstitial nephritis secondary to adalimumab therapy (epmc).pdf DeepDyve Pubget Overpricing